Graft Failure
Publisher
Springer New York
Reference23 articles.
1. Ahmed, N., Leung, K.S., Rosenblatt, H., Bollard, C.M., Gottschalk, S., Myers, G.D., et al. (2008). Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. Biol Blood Marrow Transplant, 14:1298–1304. 2. Byrne, B.J., Horwitz, M., Long, G.D., Gasparetto, C., Sullivan, K.M., Chute, J., et al. (2008). Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. Bone Marrow Transplant, 41:39–43. 3. Champlin, R.E., Horowitz, M.M., van Bekkum, D.W., Camitta, B.M., Elfenbein, G.E., Gale, R.P., et al. (1989). Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood, 73:606–613. 4. Chan, K.W., Grimley, M.S., Taylor, C., Wall, D.A. (2008). Early identification and management of graft failure after unrelated cord blood transplantation. Bone Marrow Transplant, 42:35–41. 5. Chewning, J.H., Castro-Malaspina, H., Jakubowski, A., Kernan, N.A., Papadopoulos, E.B., Small, T.N., et al. (2007). Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biol Blood Marrow Transplant, 13:1313–1323.
|
|